Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Frohn, C; Doehn, C; Durek, C; Böhle, A; Schlenke, P; Jocham, D; Kirchner, H.
Feasibility of the adoptive transfusion of allogenic human leukocyte antigen-matched natural killer cells in patients with renal cell carcinoma.
J Immunother. 2000; 23(4):499-504 Doi: 10.1097/00002371-200007000-00014
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Schlenke Peter
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Patients with metastasized renal cell carcinoma have a poor prognosis with conventional therapies. The feasibility and safety of donating purified natural killer (NK) cells without additional cytokines were evaluated. In contrast to all previous studies, the NK cells were derived from allogenic donors. The NK cell donors were HLA-C matched to enable NK cell inhibition via killer cell inhibitory receptors and HLA-C. This should obviate a graft-versus-host reaction against nonmalignant HLA-expressing tissues in the allogenic constellation. The average number of cells applied per transfusion was 1.02 +/- 0.265 x 10(9). The purity of the NK cells was 85% to 95%, and most of the contaminating cells were monocytes. Twenty-six transfusions given to 11 patients did not cause any minor or major adverse effects, with the exception of one episode of transient fever. One patient had an objective regression of his lung metastases that had been progressing continuously before. No cytotoxic HLA antibodies could be detected 3 weeks after the transfusions. The observed tolerance to this therapeutic regimen suggests the need for further studies with increased doses of cytokine-activated NK cells.
Find related publications in this database (using NLM MeSH Indexing)
Adoptive Transfer - adverse effects Adoptive Transfer - methods
Adult -
Aged -
Antigens, CD - analysis
Carcinoma, Renal Cell - therapy
Feasibility Studies -
HLA-C Antigens - immunology
Humans -
Kidney Neoplasms - therapy
Killer Cells, Natural - immunology Killer Cells, Natural - transplantation
Lymphocyte Count -
Middle Aged -
Neoplasm Metastasis -

Find related publications in this database (Keywords)
adoptive immunotherapy
natural killer cells
renal cell carcinoma
feasibility trial
© Med Uni GrazImprint